Montaruli B, Voorberg J, Tamponi G, Borchiellini A, Muleo G, Pannocchia A, van Mourik J A, Schinco P
Department of Medicine, University of Turin, Italy.
Eur J Haematol. 1996 Jul;57(1):96-100. doi: 10.1111/j.1600-0609.1996.tb00496.x.
APC resistance, due to a point mutation in factor V at amino acid position Arg506, has been identified as a major cause of inherited thrombophilia. Here we report the presence of the factor V Arg506-->Gln mutation in 2 Italian families. In 1 family 3 subjects heterozygous and 2 subjects homozygous for the factor V Arg506-->Gln mutation were identified. The only subject who developed a thrombotic event was a 20-yr-old girl who was found to be homozygous for the factor V Arg506-->Gln mutation. In the second family 10 subjects were identified to be heterozygous for the factor V Arg506-->Gln mutation; among them 2 developed a thrombotic event. In the same family 2 individuals were found to be homozygous for the mutation: the first had a myocardial infarction at age 25 yr and the second suffered from multiple episodes of deep venous thrombosis and had a stroke at age 24 yr. These data show that the risk of developing deep venous thrombosis for the carriers of the factor V Arg506-->Gln mutation is high in the families investigated. Furthermore our data imply that the factor V Arg506-->Gln mutation in its homozygous form may relate to myocardial infarction and stroke.
由于凝血因子V第506位氨基酸发生点突变导致的活化蛋白C(APC)抵抗,已被确认为遗传性血栓形成倾向的主要原因。在此,我们报告在2个意大利家庭中存在凝血因子V Arg506→Gln突变。在1个家庭中,鉴定出3名该凝血因子V Arg506→Gln突变的杂合子受试者和2名纯合子受试者。唯一发生血栓事件的受试者是一名20岁女孩,她被发现为凝血因子V Arg506→Gln突变的纯合子。在第二个家庭中,鉴定出10名凝血因子V Arg506→Gln突变的杂合子受试者;其中2人发生了血栓事件。在同一家庭中,发现2人是该突变的纯合子:第一个人在25岁时发生心肌梗死,第二个人患有多次深静脉血栓形成,并在24岁时发生中风。这些数据表明,在所研究的家庭中,凝血因子V Arg506→Gln突变携带者发生深静脉血栓形成的风险很高。此外,我们的数据表明,纯合形式的凝血因子V Arg506→Gln突变可能与心肌梗死和中风有关。